Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

OTULIN deficiency in ORAS causes cell type-specific LUBAC degradation, dysregulated TNF signalling and cell death.

Damgaard RB, Elliott PR, Swatek KN, Maher ER, Stepensky P, Elpeleg O, Komander D, Berkun Y.

EMBO Mol Med. 2019 Mar;11(3). pii: e9324. doi: 10.15252/emmm.201809324.

2.

Pyogenic sacroiliitis in children: don't forget the very young.

Lavi E, Gileles-Hillel A, Simanovsky N, Averbuch D, Wexler ID, Berkun Y.

Eur J Pediatr. 2019 Apr;178(4):575-579. doi: 10.1007/s00431-019-03333-8. Epub 2019 Feb 7.

PMID:
30734096
3.

Japanese scoring systems to predict resistance to intravenous immunoglobulin in Kawasaki disease were unreliable for Caucasian Israeli children.

Arane K, Mendelsohn K, Mimouni M, Mimouni F, Koren Y, Brik Simon D, Bahat H, Hanna Helou M, Mendelson A, Hezkelo N, Glatstein M, Berkun Y, Eisenstein E, Butbul YA, Brik R, Hashkes PJ, Uziel Y, Harel L, Amarilyo G.

Acta Paediatr. 2018 Dec;107(12):2179-2184. doi: 10.1111/apa.14418. Epub 2018 Jun 25.

PMID:
29797463
4.

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies.

Sanchez GAM, Reinhardt A, Ramsey S, Wittkowski H, Hashkes PJ, Berkun Y, Schalm S, Murias S, Dare JA, Brown D, Stone DL, Gao L, Klausmeier T, Foell D, de Jesus AA, Chapelle DC, Kim H, Dill S, Colbert RA, Failla L, Kost B, O'Brien M, Reynolds JC, Folio LR, Calvo KR, Paul SM, Weir N, Brofferio A, Soldatos A, Biancotto A, Cowen EW, Digiovanna JJ, Gadina M, Lipton AJ, Hadigan C, Holland SM, Fontana J, Alawad AS, Brown RJ, Rother KI, Heller T, Brooks KM, Kumar P, Brooks SR, Waldman M, Singh HK, Nickeleit V, Silk M, Prakash A, Janes JM, Ozen S, Wakim PG, Brogan PA, Macias WL, Goldbach-Mansky R.

J Clin Invest. 2018 Jul 2;128(7):3041-3052. doi: 10.1172/JCI98814. Epub 2018 Jun 11.

5.

A high and equal prevalence of the Q703K variant in NLRP3 patients with autoinflammatory symptoms and ethnically matched controls.

Lidar M, Brantz Y, Shinar Y, Reznik-Wolf H, Livneh A, Ben Zvi I, Cohen R, Berkun Y, Hashkes PJ, Peleg H, Kessel A, Slobodin G, Rozenbaum M, Goldzweig O, Pras E.

Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):82-85. Epub 2017 Oct 6.

PMID:
29148409
6.

Adenosine Deaminase 2 Deficiency: More Than Monogenic Vasculitis.

Berkun Y, Segel R, Navon-Elkan P.

Isr Med Assoc J. 2017 Jul;19(7):435-437. Review. No abstract available.

7.

High-dose aspirin for Kawasaki disease: outdated myth or effective aid?

Amarilyo G, Koren Y, Brik Simon D, Bar-Meir M, Bahat H, Helou MH, Mendelson A, Hezkelo N, Chodick G, Berkun Y, Eisenstein E, Butbul Aviel Y, Barkai G, Bolkier Y, Padeh S, Brik R, Hashkes PJ, Harel L, Uziel Y.

Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):209-212. Epub 2017 Jan 5.

PMID:
28079513
8.

Therapy with eculizumab for patients with CD59 p.Cys89Tyr mutation.

Mevorach D, Reiner I, Grau A, Ilan U, Berkun Y, Ta-Shma A, Elpeleg O, Shorer Z, Edvardson S, Tabib A.

Ann Neurol. 2016 Nov;80(5):708-717. doi: 10.1002/ana.24770. Epub 2016 Sep 19.

PMID:
27568864
9.

Extending the Clinical Phenotype of Adenosine Deaminase 2 Deficiency.

Ben-Ami T, Revel-Vilk S, Brooks R, Shaag A, Hershfield MS, Kelly SJ, Ganson NJ, Kfir-Erenfeld S, Weintraub M, Elpeleg O, Berkun Y, Stepensky P.

J Pediatr. 2016 Oct;177:316-320. doi: 10.1016/j.jpeds.2016.06.058. Epub 2016 Aug 8.

PMID:
27514238
10.

Familial Mediterranean fever.

Padeh S, Berkun Y.

Curr Opin Rheumatol. 2016 Sep;28(5):523-9. doi: 10.1097/BOR.0000000000000315. Review.

PMID:
27286236
11.

Update on Auto-Inflammatory Diseases and Familial Mediterranean Fever.

Berkun Y, Eisenstein EM.

Isr Med Assoc J. 2016 Mar-Apr;18(3-4):221-4. Review. No abstract available.

12.

Behçet's disease and cerebral sinus vein thrombosis in children: a case study and review of the literature.

Rottenstreich A, Machol K, Eisenstein EM, Padeh S, Klar A, Livneh A, Berkun Y.

Clin Exp Rheumatol. 2015 Nov-Dec;33(6 Suppl 94):S163-8. Epub 2015 Oct 20. Review.

PMID:
26486489
13.

Sudden onset unexplained encephalopathy in infants: think of cannabis intoxication.

Lavi E, Rekhtman D, Berkun Y, Wexler I.

Eur J Pediatr. 2016 Mar;175(3):417-20. doi: 10.1007/s00431-015-2639-9. Epub 2015 Oct 6.

PMID:
26440670
14.

Efficacy of Rituximab in Refractory Cold Agglutinin Hemolytic Anemia in a Patient with Ataxia-Telangiectasia.

Abdulhag UN, Liebster D, Eisenstein EM, Berkun Y.

Isr Med Assoc J. 2015 Jul;17(7):455-6. No abstract available.

15.

Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib.

Jabbari A, Dai Z, Xing L, Cerise JE, Ramot Y, Berkun Y, Sanchez GA, Goldbach-Mansky R, Christiano AM, Clynes R, Zlotogorski A.

EBioMedicine. 2015 Feb 26;2(4):351-5. doi: 10.1016/j.ebiom.2015.02.015. eCollection 2015 Apr.

16.

Enteroviral Infection in a Patient with BLNK Adaptor Protein Deficiency.

NaserEddin A, Shamriz O, Keller B, Alzyoud RM, Unger S, Fisch P, Prus E, Berkun Y, Averbuch D, Shaag A, Wahadneh AM, Conley ME, Warnatz K, Elpeleg O, Stepensky P.

J Clin Immunol. 2015 May;35(4):356-60. doi: 10.1007/s10875-015-0164-2. Epub 2015 Apr 17.

PMID:
25893637
17.

Seasonality of birth of patients with juvenile idiopathic arthritis.

Berkun Y, Lewy H, Padeh S, Laron Z.

Clin Exp Rheumatol. 2015 Jan-Feb;33(1):122-6. Epub 2015 Jan 8.

PMID:
25571969
18.

Iatrogenic Cushing Syndrome due to Intranasal Dexamethasone.

Rottenstreich A, Wexler ID, Abu-Libdeh A, Berkun Y.

Clin Pediatr (Phila). 2015 Oct;54(12):1215-7. doi: 10.1177/0009922814563927. Epub 2014 Dec 21. No abstract available.

PMID:
25533884
19.

Disturbed B and T cell homeostasis and neogenesis in patients with ataxia telangiectasia.

Kraus M, Lev A, Simon AJ, Levran I, Nissenkorn A, Levi YB, Berkun Y, Efrati O, Amariglio N, Rechavi G, Somech R.

J Clin Immunol. 2014 Jul;34(5):561-72. doi: 10.1007/s10875-014-0044-1. Epub 2014 May 1.

PMID:
24789685
20.

Antiphospholipid antibodies in neonates with stroke--a unique entity or variant of antiphospholipid syndrome?

Berkun Y, Simchen MJ, Strauss T, Menashcu S, Padeh S, Kenet G.

Lupus. 2014 Sep;23(10):986-93. doi: 10.1177/0961203314531842. Epub 2014 Apr 11.

PMID:
24729280
21.

Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.

Navon Elkan P, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, Zlotogorski A, Berkun Y, Press JJ, Mukamel M, Voth I, Hashkes PJ, Harel L, Hoffer V, Ling E, Yalcinkaya F, Kasapcopur O, Lee MK, Klevit RE, Renbaum P, Weinberg-Shukron A, Sener EF, Schormair B, Zeligson S, Marek-Yagel D, Strom TM, Shohat M, Singer A, Rubinow A, Pras E, Winkelmann J, Tekin M, Anikster Y, King MC, Levy-Lahad E.

N Engl J Med. 2014 Mar 6;370(10):921-31. doi: 10.1056/NEJMoa1307362. Epub 2014 Feb 19.

22.

Diagnosis and classification of juvenile idiopathic arthritis.

Eisenstein EM, Berkun Y.

J Autoimmun. 2014 Feb-Mar;48-49:31-3. doi: 10.1016/j.jaut.2014.01.009. Epub 2014 Jan 21. Review.

PMID:
24461383
23.

Diagnostic criteria of familial Mediterranean fever.

Berkun Y, Eisenstein EM.

Autoimmun Rev. 2014 Apr-May;13(4-5):388-90. doi: 10.1016/j.autrev.2014.01.045. Epub 2014 Jan 11. Review.

PMID:
24424166
24.

Familial Mediterranean fever: a critical digest of the 2012-2013 literature.

Eisenstein EM, Berkun Y, Ben-Chetrit E.

Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):103-7. Epub 2013 Sep 9. Review.

PMID:
24064023
25.

The Thr224Asn mutation in the VPS45 gene is associated with the congenital neutropenia and primary myelofibrosis of infancy.

Stepensky P, Saada A, Cowan M, Tabib A, Fischer U, Berkun Y, Saleh H, Simanovsky N, Kogot-Levin A, Weintraub M, Ganaiem H, Shaag A, Zenvirt S, Borkhardt A, Elpeleg O, Bryant NJ, Mevorach D.

Blood. 2013 Jun 20;121(25):5078-87. doi: 10.1182/blood-2012-12-475566. Epub 2013 Apr 18.

26.

Pentraxin 3 is a marker of early joint inflammation in patients with juvenile idiopathic arthritis.

Padeh S, Farzam N, Chayen G, Gerstein M, Berkun Y.

Immunol Res. 2013 Jul;56(2-3):444-50. doi: 10.1007/s12026-013-8417-8.

PMID:
23579776
27.

Chronic chilblains: the clinical presentation and disease course in a large paediatric series.

Padeh S, Gerstein M, Greenberger S, Berkun Y.

Clin Exp Rheumatol. 2013 May-Jun;31(3):463-8. Epub 2013 Feb 15.

PMID:
23414913
28.

Dermatologic manifestations of ataxia-telangiectasia syndrome.

Greenberger S, Berkun Y, Ben-Zeev B, Levi YB, Barziliai A, Nissenkorn A.

J Am Acad Dermatol. 2013 Jun;68(6):932-6. doi: 10.1016/j.jaad.2012.12.950. Epub 2013 Jan 27.

PMID:
23360865
29.

Pharmacokinetics of colchicine in pediatric and adult patients with familial Mediterranean fever.

Berkun Y, Wason S, Brik R, Butbul Y, Ben-Chetrit E, Hashkes PJ, Livneh A, Ozen S, Ozdogan H, Faulkner R, Davis MW.

Int J Immunopathol Pharmacol. 2012 Oct-Dec;25(4):1121-30.

PMID:
23298502
30.

Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis.

Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat N, Horneff G, Brik R, McCann L, Kasapcopur O, Rutkowska-Sak L, Schneider R, Berkun Y, Calvo I, Erguven M, Goffin L, Hofer M, Kallinich T, Oliveira SK, Uziel Y, Viola S, Nistala K, Wouters C, Cimaz R, Ferrandiz MA, Flato B, Gamir ML, Kone-Paut I, Grom A, Magnusson B, Ozen S, Sztajnbok F, Lheritier K, Abrams K, Kim D, Martini A, Lovell DJ; PRINTO; PRCSG.

N Engl J Med. 2012 Dec 20;367(25):2396-406. doi: 10.1056/NEJMoa1205099.

31.

FMF - clinical features, new treatments and the role of genetic modifiers: a critical digest of the 2010-2012 literature.

Berkun Y, Eisenstein E, Ben-Chetrit E.

Clin Exp Rheumatol. 2012 May-Jun;30(3 Suppl 72):S90-5. Epub 2012 Sep 25. Review.

PMID:
23009752
32.

Colchicine is a safe drug in children with familial Mediterranean fever.

Padeh S, Gerstein M, Berkun Y.

J Pediatr. 2012 Dec;161(6):1142-6. doi: 10.1016/j.jpeds.2012.05.047. Epub 2012 Jun 26.

PMID:
22738946
33.

Novel immunotherapy for malignant melanoma with a monoclonal antibody that blocks CEACAM1 homophilic interactions.

Ortenberg R, Sapir Y, Raz L, Hershkovitz L, Ben Arav A, Sapoznik S, Barshack I, Avivi C, Berkun Y, Besser MJ, Ben-Moshe T, Schachter J, Markel G.

Mol Cancer Ther. 2012 Jun;11(6):1300-10. doi: 10.1158/1535-7163.MCT-11-0526. Epub 2012 Mar 30.

34.

Cellular interactions of synovial fluid γδ T cells in juvenile idiopathic arthritis.

Bendersky A, Marcu-Malina V, Berkun Y, Gerstein M, Nagar M, Goldstein I, Padeh S, Bank I.

J Immunol. 2012 May 1;188(9):4349-59. doi: 10.4049/jimmunol.1102403. Epub 2012 Mar 26.

35.

NOD2/CARD15 gene mutations in patients with familial Mediterranean fever.

Berkun Y, Karban A, Padeh S, Pras E, Shinar Y, Lidar M, Livneh A, Bujanover Y.

Semin Arthritis Rheum. 2012 Aug;42(1):84-8. doi: 10.1016/j.semarthrit.2011.12.002. Epub 2012 Jan 12.

PMID:
22244368
36.

Impact of persistent antiphospholipid antibodies on risk of incident symptomatic thromboembolism in children: a systematic review and meta-analysis.

Kenet G, Aronis S, Berkun Y, Bonduel M, Chan A, Goldenberg NA, Holzhauer S, Iorio A, Journeycake J, Junker R, Male C, Manco-Johnson M, Massicotte P, Mesters R, Monagle P, van Ommen H, Rafini L, Simioni P, Young G, Nowak-Göttl U.

Semin Thromb Hemost. 2011 Oct;37(7):802-9. doi: 10.1055/s-0031-1297171. Epub 2011 Dec 20. Review.

PMID:
22187403
37.

The relative contribution of environmental and genetic factors to phenotypic variation in familial Mediterranean fever (FMF).

Ben-Zvi I, Brandt B, Berkun Y, Lidar M, Livneh A.

Gene. 2012 Jan 10;491(2):260-3. doi: 10.1016/j.gene.2011.10.005. Epub 2011 Oct 13.

PMID:
22019429
38.

T-cell compartment in synovial fluid of pediatric patients with JIA correlates with disease phenotype.

Amariglio N, Klein A, Dagan L, Lev A, Padeh S, Rechavi G, Berkun Y, Somech R.

J Clin Immunol. 2011 Dec;31(6):1021-8. doi: 10.1007/s10875-011-9580-0. Epub 2011 Sep 8.

PMID:
21901393
39.

Cellular and clinical report of new Griscelli syndrome type III cases.

Westbroek W, Klar A, Cullinane AR, Ziegler SG, Hurvitz H, Ganem A, Wilson K, Dorward H, Huizing M, Tamimi H, Vainshtein I, Berkun Y, Lavie M, Gahl WA, Anikster Y.

Pigment Cell Melanoma Res. 2012 Jan;25(1):47-56. doi: 10.1111/j.1755-148X.2011.00901.x. Epub 2011 Oct 3.

40.

Children with oligoarticular juvenile idiopathic arthritis are at considerable risk for growth retardation.

Padeh S, Pinhas-Hamiel O, Zimmermann-Sloutskis D, Berkun Y.

J Pediatr. 2011 Nov;159(5):832-837.e1-2. doi: 10.1016/j.jpeds.2011.04.012. Epub 2011 May 31.

PMID:
21621220
41.

Neurologic presentation in children with ataxia-telangiectasia: is small head circumference a hallmark of the disease?

Nissenkorn A, Levi YB, Vilozni D, Berkun Y, Efrati O, Frydman M, Yahav J, Waldman D, Somech R, Shenhod E, Menascu S, Ben-Zeev B.

J Pediatr. 2011 Sep;159(3):466-471.e1. doi: 10.1016/j.jpeds.2011.02.005. Epub 2011 Mar 22.

PMID:
21429505
42.

GammadeltaT cells in juvenile idiopathic arthritis: higher percentages of synovial Vdelta1+ and Vgamma9+ T cell subsets are associated with milder disease.

Berkun Y, Bendersky A, Gerstein M, Goldstein I, Padeh S, Bank I.

J Rheumatol. 2011 Jun;38(6):1123-9. doi: 10.3899/jrheum.100938. Epub 2011 Mar 16.

PMID:
21406498
43.

The familial Mediterranean fever gene as a modifier of periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome.

Berkun Y, Levy R, Hurwitz A, Meir-Harel M, Lidar M, Livneh A, Padeh S.

Semin Arthritis Rheum. 2011 Apr;40(5):467-72. doi: 10.1016/j.semarthrit.2010.06.009. Epub 2010 Sep 9.

PMID:
20828792
44.

The feasibility and validity of forced spirometry in ataxia telangiectasia.

Vilozni D, Berkun Y, Levi Y, Weiss B, Jacobson JM, Efrati O.

Pediatr Pulmonol. 2010 Oct;45(10):1030-6. doi: 10.1002/ppul.21291.

PMID:
20717907
45.

Role of the R92Q TNFRSF1A mutation in patients with familial Mediterranean fever.

Marek-Yagel D, Berkun Y, Padeh S, Lidar M, Shinar Y, Bar-Joseph I, Reznik-Wolf H, Langevitz P, Livneh A, Pras E.

Arthritis Care Res (Hoboken). 2010 Sep;62(9):1294-8. doi: 10.1002/acr.20213.

46.

EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria.

Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario MO, Silva CA, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella AI, Olivieri AN, Alpigiani MG, Rumba I, Sztajnbok F, Tambic-Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chasnyk V, Sengler C, Klein-Gitelman M, Djeddi D, Nuno L, Pruunsild C, Brunner J, Kondi A, Pagava K, Pederzoli S, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Ann Rheum Dis. 2010 May;69(5):798-806. doi: 10.1136/ard.2009.116657.

PMID:
20413568
47.

Familial Mediterranean Fever in the first two years of life: a unique phenotype of disease in evolution.

Padeh S, Livneh A, Pras E, Shinar Y, Lidar M, Feld O, Berkun Y.

J Pediatr. 2010 Jun;156(6):985-989. doi: 10.1016/j.jpeds.2009.12.010. Epub 2010 Mar 15.

PMID:
20227729
48.

Familial Mediterranean fever in children presenting with attacks of fever alone.

Padeh S, Livneh A, Pras E, Shinar Y, Lidar M, Feld O, Berkun Y.

J Rheumatol. 2010 Apr;37(4):865-9. doi: 10.3899/jrheum.090687. Epub 2010 Mar 1.

PMID:
20194447
49.

Pregnancy outcomes in women with familial Mediterranean fever receiving colchicine: is amniocentesis justified?

Ben-Chetrit E, Ben-Chetrit A, Berkun Y, Ben-Chetrit E.

Arthritis Care Res (Hoboken). 2010 Feb;62(2):143-8. doi: 10.1002/acr.20061.

50.

TNF activates a NF-kappaB-regulated cellular program in human CD45RA- regulatory T cells that modulates their suppressive function.

Nagar M, Jacob-Hirsch J, Vernitsky H, Berkun Y, Ben-Horin S, Amariglio N, Bank I, Kloog Y, Rechavi G, Goldstein I.

J Immunol. 2010 Apr 1;184(7):3570-81. doi: 10.4049/jimmunol.0902070. Epub 2010 Feb 24.

Supplemental Content

Loading ...
Support Center